Skip to main content
Premium Trial:

Request an Annual Quote

Diagnostic Hybrids Licenses HIV PGx Technology from Case Western

NEW YORK (GenomeWeb News) – Diagnostic Hybrids this week announced that it has licensed exclusive worldwide rights from Case Western Reserve University to pharmacogenomics test technology for monitoring HIV treatment.

The Athens, Ohio-based firm licensed novel yeast-based virus cloning technology invented by Eric Arts, an associate professor of medicine in the division of infectious diseases, department of medicine, at Case Western Reserve School of Medicine. It said that the technology can monitor the success of HIV treatments by determining drug resistance and disease "strength" of the virus.

Diagnostic Hybrids and Case Western were awarded a $5 million grant last year from the Ohio Third Frontier Biomedical Research and Commercialization Program to accelerate commercial development of a suite of diagnostic products for HIV, hepatitis, and influenza using the yeast vector technology.

Financial and other terms of the license were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.